Qube Research & Technologies LTD Novavax Inc Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $1.68 Million - $7.04 Million	92,529 Added 199.2%	138,980 $2.53 Million
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $3.16 Million - $6.56 Million	-87,142 Reduced 65.23%	46,451 $2.39 Million
Q1 2022 May 09, 2022	BUY	$69.73 - $142.9 $9.32 Million - $19.1 Million	133,593 New	133,593 $9.84 Million
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $1.77 Million - $2.69 Million	-9,930 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $1.2 Million - $2.56 Million	9,930 New	9,930 $2.11 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $405,747 - $718,843	-5,153 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$79.44 - $178.51 $409,354 - $919,862	5,153 New	5,153 $558,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.